• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Medical Tubing and Extrusion

Medical tubing and extrusion technologies

  • Technologies
    • Balloons
    • Brain-computer interfaces
    • Cardiac Implants
    • Catheters
    • Endoscopes
    • Heart valves
    • Pulsed Field Ablation
  • Components
    • Connectors
    • Needles and Injections
    • Seals
    • Tubing Components
  • Manufacturing
    • Coatings
    • Extrusions
    • Machining
    • Molding
      • Injection Molding
      • Insert molding
      • Mold Components
    • Tools
  • Materials
    • Advanced Materials
    • Metals
    • Nitinol
    • Plastics
    • Silicone
  • Business
    • Distribution Agreements
    • Legal News
    • Mergers & Acquisitions
    • Partnerships
    • Personnel Moves
  • Regulatory
    • 510(k)
    • CE Mark
    • FDA Breakthrough Designation
    • ISO Certification
    • Pre-Market Approval (PMA)
    • Recalls
  • Suppliers
  • About Us

4 catheter-based devices to watch for in 2021

April 28, 2021 By Danielle Kirsh

Amplatzer Amulet LAAAbbott: Amplatzer Amulet left atrial appendage occluder and delivery system

One device Abbott (NYSE:ABT) has in its pipeline for 2021 is the Amplatzer Amulet left atrial appendage (LAA) occluder device.

Abbott’s Amplatzer Amulet occluder device is designed for a minimally invasive, catheter-based procedure to seal the LAA at its opening, minimizing the opportunity for blood clots to form in the LAA, migrate into the bloodstream and possibly cause stroke in patients experiencing atrial fibrillation (AF).

The device offers cross-sectional orifice coverage; flexible, braided nitinol mesh construction; controlled, precise deployment; a complete seal with the ability to conform to the inner wall of the LAA and to be recaptured and repositioned. It has a broad size range with landing zones from 11 to 31 mm in diameter and proximal device positioning.

Amplatzer Amulet is approved in many regions outside the U.S. and the company is following the typical regulatory timelines for U.S. approval and will share updates on its progress later this year.

“Our latest and leading minimally invasive catheter-based therapies are becoming the new standards of care for treating structural heart issues because they are less invasive than conventional surgery, which allows care for extremely vulnerable patient populations, both young and old,” an Abbott spokesperson told Medical Tubing + Extrusion in an email. Additionally, we have supporting real-world and clinical data to show that our catheter-based therapies are safe, effective and durable treatment options that deliver the best clinical outcomes for patients. Abbott is at the forefront of minimally invasive treatments for structural heart diseases and has the most comprehensive portfolio of on-market and pipeline structural heart treatments available today.”

Abbott has several catheter-based devices in its pipeline this year, including:

  • MitraClip transcatheter mitral valve repair system.
  • TriClip transcatheter tricuspid valve repair system.
  • Tendyne and Cephea transcatheter mitral valve implantation systems.
  • Portico transcatheter aortic valve replacement with FlexNav delivery system and Navitor transcatheter aortic valve replacement.
  • Amplatzer PFO occluder: patent foramen ovale closure device.
  • Amplatzer Piccolo occluder: minimally invasive, transcatheter treatment device for premature babies with patent ductus.

Next >>

Pages: Page 1 Page 2 Page 3 Page 4 Page 5

Filed Under: Catheters Tagged With: Abbott, BD, Cardiovascular Systems, teleflex

About Danielle Kirsh

Danielle Kirsh is an award-winning journalist and senior editor for Medical Tubing + Extrusion, Medical Design & Outsourcing and MassDevice. She received her bachelor's degree in broadcast journalism and mass communication from Norfolk State University and is pursuing her master's in global strategic communications at the University of Florida. You can connect with her on Twitter and LinkedIn, or email her at dkirsh@wtwhmedia.com.

Primary Sidebar

“mte
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest trends and developments in medical tubing and extrusion.
MDO ad

Sponsored Content

A new way to access scientific papers?

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Inv Logo

MASSDEVICE MEDICAL NETWORK

MassDevice
DeviceTalks
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World
Drug Delivery Business News

Medical Tubing + Extrusion

Subscribe to our E-Newsletter
Advertise with us
About
Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS